Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk

被引:281
|
作者
King, Valencia [1 ]
Brooks, Jennifer D. [2 ]
Bernstein, Jonine L. [2 ]
Reiner, Anne S. [2 ]
Pike, Malcolm C. [2 ]
Morris, Elizabeth A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
关键词
HORMONE REPLACEMENT THERAPY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC FEATURES; MENSTRUAL-CYCLE; TISSUE; DENSITY; WOMEN; PATTERNS; CLASSIFICATION; AGE;
D O I
10.1148/radiol.11102156
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging. Materials and Methods: A waiver of authorization was granted by the institutional review board for this retrospective HIPAA-compliant study. Among 1275 women who underwent breast MR imaging screening between December 2002 and February 2008, 39 breast carcinoma cases were identified. Two comparisons were performed: In one comparison, two normal controls-those of the women with negative (benign) findings at breast MR imaging-were matched to each breast cancer case on the basis of age and date of MR imaging. In the second comparison, one false-positive control-that of a woman with suspicious but nonmalignant findings at MR imaging-was similarly matched to each breast cancer case. Two readers independently rated the level of MR imaging-depicted BPE and the amount of MR imaging-depicted FGT by using a categorical scale: BPE was categorized as minimal, mild, moderate, or marked, and FGT was categorized as fatty, scattered, heterogeneously dense, or dense. Results: Compared with the odds ratio (OR) for a normal control, the OR for breast cancer increased significantly with increasing BPE: The ORs for moderate or marked BPE versus minimal or mild BPE were 10.1 (95% confidence interval [CI]: 2.9, 35.3; P < .001) and 3.3 (95% CI: 1.3, 8.3; P = .006) for readers 1 and 2, respectively. Similar odds were seen when the false-positive controls were compared with the breast cancer cases: The ORs for moderate or marked BPE versus minimal or mild BPE were 5.1 (95% CI: 1.4, 19.1; P = .005) and 3.7 (95% CI: 1.2, 11.2; P = .013) for readers 1 and 2, respectively. The breast cancer odds also increased with increasing FGT, but the BPE findings remained significant after adjustment for FGT. Conclusion: Increased BPE is strongly predictive of breast cancer odds. (C) RSNA, 2011
引用
收藏
页码:50 / 60
页数:11
相关论文
共 50 条
  • [31] Preoperative breast MR imaging in newly diagnosed breast cancer: Comparison of outcomes based on mammographic modality, breast density and breast parenchymal enhancement
    Elmi, Azadeh
    Conant, Emily F.
    Kozlov, Andrew
    Young, Anthony J.
    Long, Qi
    Doot, Robert K.
    McDonald, Elizabeth S.
    CLINICAL IMAGING, 2021, 70 : 18 - 24
  • [32] Parenchymal enhancement on breast MRI may be a marker for cancer risk: correlation of parenchymal enhancement with breast density.
    Arkani, S.
    Newstead, G.
    Chen, V
    Cranford, C.
    Karczmar, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S126 - S126
  • [33] Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
    Dontchos, Brian N.
    Rahbar, Habib
    Partridge, Savannah C.
    Korde, Larissa A.
    Lam, Diana L.
    Scheel, John R.
    Peacock, Sue
    Lehman, Constance D.
    RADIOLOGY, 2015, 276 (02) : 371 - 380
  • [34] Assessment of Quantitative Magnetic Resonance Imaging Background Parenchymal Enhancement Parameters to Improve Determination of Individual Breast Cancer Risk
    Lam, Diana L.
    Hippe, Daniel S.
    Kitsch, Averi E.
    Partridge, Savannah C.
    Rahbar, Habib
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2019, 43 (01) : 85 - 92
  • [35] Impact of Background Parenchymal Enhancement in Preoperative Magnetic Resonance Imaging Breast Assessment for Women with Newly Diagnosed Breast Cancer
    Wan, W. S.
    Lee, C. Y.
    Lui, C. Y.
    HONG KONG JOURNAL OF RADIOLOGY, 2015, 18 (02): : 141 - 145
  • [36] Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review
    Bauer, Ethan
    Levy, Miri Sklair
    Domachevsky, Liran
    Anaby, Debbie
    Nissan, Noam
    CLINICAL IMAGING, 2022, 83 : 41 - 50
  • [37] Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type
    Dilorenzo, Giuseppe
    Telegrafo, Michele
    La Forgia, Daniele
    Ianora, Amato Antonio Stabile
    Moschetta, Marco
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 113 : 148 - 152
  • [38] Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
    Hruska, Carrie B.
    Scott, Christopher G.
    Conners, Amy Lynn
    Whaley, Dana H.
    Rhodes, Deborah J.
    Carter, Rickey E.
    O'Connor, Michael K.
    Hunt, Katie N.
    Brandt, Kathleen R.
    Vachon, Celine M.
    BREAST CANCER RESEARCH, 2016, 18
  • [39] Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
    Carrie B. Hruska
    Christopher G. Scott
    Amy Lynn Conners
    Dana H. Whaley
    Deborah J. Rhodes
    Rickey E. Carter
    Michael K. O’Connor
    Katie N. Hunt
    Kathleen R. Brandt
    Celine M. Vachon
    Breast Cancer Research, 18
  • [40] Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
    Carrie B. Hruska
    Jennifer R. Geske
    Tiffinee N. Swanson
    Alyssa N. Mammel
    David S. Lake
    Armando Manduca
    Amy Lynn Conners
    Dana H. Whaley
    Christopher G. Scott
    Rickey E. Carter
    Deborah J. Rhodes
    Michael K. O’Connor
    Celine M. Vachon
    Breast Cancer Research, 20